cephalosporin c has been researched along with cefmenoxime in 85 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 68 (80.00) | 18.7374 |
1990's | 13 (15.29) | 18.2507 |
2000's | 4 (4.71) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huang, SP; Ikeda, D; Kondo, S; Koyama, Y; Takeuchi, T | 1 |
Miyake, A; Nishimura, T; Yoshimura, Y | 1 |
Hiruma, R; Nishino, T; Obana, Y; Otsuki, M; Tashima, M | 1 |
Hishikawa, T; Kusunoki, T; Matsumoto, K; Nagatake, T; Sakamoto, T; Tsuchiya, K; Uzuka, Y | 1 |
Hiraoka, M; Inoue, M; Matsui, H; Mitsuhashi, S | 1 |
Fukasawa, M; Mutoh, M; Nagata, H; Nouda, H; Okuda, T; Ueda, S; Yamada, H | 1 |
Hirano, M; Hiraoka, M; Inoue, M; Masuyoshi, S; Mitsuhashi, S; Tomatsu, K | 1 |
Black, WA; Bowie, WR; Chan, DG; Shaw, CE | 1 |
Brunham, RC; Le Saux, NM; Plummer, FA; Ronald, AR; Slaney, LA | 1 |
Hino, J; Kawane, H; Kawanishi, M; Matsushima, T; Nakagawa, Y; Niki, Y; Soejima, R; Sumi, M; Umeki, S; Watanabe, M | 1 |
Ishikawa, K; Ito, T; Kawai, S; Kobayashi, H; Nakayama, I; Saito, A; Takeuchi, K; Tamura, M; Tomizawa, M; Yajima, O | 2 |
Gohro, T; Igawa, K; Inoke, T; Kato, S; Kumamoto, Y; Okayama, S; Sakai, S; Tabata, S; Tanda, H; Tsunekawa, T | 1 |
Jalanko, E; Renkonen, OV; Scheinin, L; Valle, T | 1 |
Easmon, CS; Ison, CA; Woodford, N | 1 |
Beskid, G; Durkin, JW; Fallat, V; Lipschitz, ER; McGarry, DH; Siebelist, J | 1 |
Hohl, P; Kafader, FM; Salfinger, M | 1 |
Katsu, K; Kitoh, K; Moriyama, M; Watanabe, N | 1 |
Blanchin, MD; Fabre, H; Mandrou, B; Rondot-Dudragne, ML | 1 |
Kim, KS | 1 |
Shimada, K | 1 |
Aldridge, KE; Sanders, CV; Schiro, DD | 1 |
Chang, D; Garland, W; Oldfield, N; Town, C | 1 |
Chin, NX; Labthavikul, P; Neu, HC | 2 |
Nagai, A; Yoneda, T | 1 |
Hamana, Y; Inoue, M; Mitsuhashi, S; Okamoto, S | 1 |
Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
Arnold, K; Chau, PY; Leung, YK; Ng, WW | 1 |
Koyama, M; Nakagawa, K | 1 |
Barry, AL; Jones, RN | 1 |
Houben, AW; Stobberingh, E; van Boven, CP | 1 |
Andrews, JM; Piddock, LJ; Wise, R | 1 |
Imaizumi, H; Sadaki, H; Saikawa, I; Sugimoto, Y; Tai, M; Takeda, K | 1 |
Demachi, K; Fukuda, H; Hayakawa, H; Kajita, T; Nakajima, Y; Onoda, M; Sadaki, H; Saikawa, I; Sakai, H; Tai, M | 1 |
Abe, N; Arai, H; Hashiba, K; Hirai, S; Hiraiwa, T; Kodama, T; Nakada, Y; Omori, M; Ono, S; Tanada, K | 1 |
Hayakawa, H; Maeda, T; Matsutani, H; Nakashima, Y; Onoda, M; Saikawa, I; Sakai, H | 2 |
Fukatsu, H; Hatano, Y; Hiraiwa, S; Miyagawa, Y; Muramatsu, T; Nonomura, H; Ohshita, H; Takamura, T; Waki, M; Yamada, Y | 1 |
Fass, RJ; Helsel, VL | 1 |
Kawamura, Y; Nakada, H; Nojima, Y; Sanzen, T; Shibata, T; Yoneda, T; Yoshida, K | 1 |
Shibata, T; Shimotori, T; Yoneda, T | 1 |
Nagai, A; Nakagawa, S; Sato, S; Shibata, T; Shimotori, T; Yoneda, T | 1 |
Hojo, T; Hori, S; Kaji, M; Miyahara, T; Okuda, S; Saito, A; Shiba, K; Shimada, J; Yamaji, T | 1 |
Kawasaki, Y; Ogawa, S; Sakamoto, Y; Tsuchihashi, N | 1 |
Inada, S; Kishimoto, H; Morishita, M; Shimokata, K; Suetsugu, S; Torikai, K; Umeda, H; Wada, M; Yamamoto, M; Yamori, S | 1 |
Takai, A | 1 |
Daly, JA; Gooch, WM | 1 |
Marsh, TD | 1 |
Goto, S; Hasebe, S; Kanno, H; Ozaki, K; Sato, K; Takagi, T; Tomizawa, M; Tsuji, A; Yakata, M; Yatagai, S | 1 |
Guenthner, SH; Norris, SM; Wenzel, RP | 1 |
Fujimura, N; Kurokawa, K; Uema, K; Yuasa, K | 1 |
Bryskier, A; Labia, R; Morand, A; Verchere-Beaur, C | 1 |
Bower, RR; Girolami, RL; Shipkowitz, NL; Stamm, JM | 1 |
Kida, M; Kuno, M; Mitsuhashi, S; Okonogi, K | 1 |
Miyawaki, T; Morimoto, A; Ochiai, M | 1 |
Fugono, T; Shirakawa, Y; Yamazaki, I | 2 |
Gruninger, RP; Khan, MY; Siddiqui, Y; Simpson, ML | 1 |
Kosakai, N; Oguri, T | 1 |
Neu, HC | 1 |
Granneman, GR; Sennello, LT | 1 |
Aoki, I; Itakura, K; Mitani, M; Usui, Y | 1 |
Kawakita, J; Kawamura, N; Ohkoshi, M; Okada, K; Satake, Y | 1 |
Ahonkhai, VI; Bancroft, U; Cherubin, CE; Shulman, MA | 1 |
Horiuchi, N; Kanai, M; Kawakami, Y; Okimura, Y | 1 |
Finegold, SM; Owens, WE | 1 |
Smith, BR | 1 |
Francisco, MA; LeFrock, JL; Schell, RF; Smith, BR | 1 |
Bryskier, A; Le Noc, D; Le Noc, P | 1 |
Actor, P; Dunn, GL; Grappel, SF; Jakas, DR; Phillips, L; Pitkin, D | 1 |
Adachi, K; Kondo, T; Tanayama, S; Yoshida, K | 1 |
Iwahi, T; Kida, M; Kondo, M; Nakao, M; Nishi, T; Noji, Y; Nozaki, Y; Takeuchi, M; Tsuchiya, K | 1 |
Fugono, T; Kita, Y; Kondo, M; Noji, Y; Tsuchiya, K; Yamazaki, I | 1 |
Ishikawa, H; Tsubouchi, H | 1 |
Li, G; Wu, J; Zhang, Y | 1 |
Dalla Costa, T; Derendorf, H | 1 |
Ballow, CH; Forrest, A; Hyatt, JM; Luzier, AB; Schentag, JJ | 1 |
Hattori, H; Kato, M; Nomura, M; Wagai, N; Yamaguchi, F | 1 |
Abe, T; Domon, H; Fukuoka, T; Harasaki, T; Hirasawa, A; Ishii, C; Iwata, M; Kakuta, M; Kawada, H; Koga, T; Kubota, M; Kuwahara, S; Masuda, N; Ohya, S; Sakagawa, E; Takenouchi, T; Utsui, Y; Yasuda, H | 1 |
Igarashi, T; Inatomi, J; Iwata, T; Katayama, H; Takamizawa, M; Wake, A | 1 |
Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
Furudoi, S; Komori, T; Ohtsuka, Y; Yoshii, T; Yoshikawa, T; Yoshioka, A | 1 |
Furuki, A; Hasegawa, M; Kanayama, A; Kobayashi, I; Matsuzaki, K; Sato, Y; Watabe, E | 1 |
Araki-Sasaki, K; Asari, S; Matsumoto, K; Mutoh, K; Nishi, I; Takatsuka, H; Tanihara, H; Yonemura, N | 1 |
3 review(s) available for cephalosporin c and cefmenoxime
Article | Year |
---|---|
[New antimicrobial agent series XXVI: cefteram pivoxil].
Topics: Bacteria; Bacterial Infections; Cefmenoxime; Cephalosporins; Humans; Tissue Distribution | 1987 |
The cephalosporin antibiotic agents--III. Third-generation cephalosporins.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Humans; Moxalactam | 1985 |
The in vitro activity, human pharmacology, and clinical effectiveness of new beta-lactam antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefmenoxime; Cefmetazole; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cephamycins; Drug Interactions; Drug Resistance, Microbial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Imipenem; Moxalactam | 1982 |
5 trial(s) available for cephalosporin c and cefmenoxime
Article | Year |
---|---|
[Comparative study of cefuzonam (CZON) with cefmenoxime in chronic respiratory tract infections by the double-blind method].
Topics: Adult; Aged; Cefmenoxime; Cefotaxime; Ceftizoxime; Cephalosporins; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1986 |
[Comparative clinical study of T-2588 and cefaclor in chronic respiratory tract infections by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Respiratory Tract Infections | 1986 |
[Comparative clinical study of T-2588 and bacampicillin in bacterial pneumonia by a double-blind method].
Topics: Adult; Aged; Aged, 80 and over; Ampicillin; Bacterial Infections; Cefmenoxime; Cephalosporins; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumonia | 1986 |
[A randomized control study on the treatment of 123 cases of bacterial infections with cefteram and cefaclor].
Topics: Bacterial Infections; Bronchitis; Cefaclor; Cefmenoxime; Cephalosporins; Cystitis; Humans; Tonsillitis | 1995 |
Modeling the response of pneumonia to antimicrobial therapy.
Topics: Anti-Infective Agents; Cefmenoxime; Ceftazidime; Cephalosporins; Ciprofloxacin; Clinical Trials as Topic; Humans; Microbial Sensitivity Tests; Models, Biological; Pneumonia, Bacterial; Predictive Value of Tests; Regression Analysis; Treatment Outcome | 1997 |
77 other study(ies) available for cephalosporin c and cefmenoxime
Article | Year |
---|---|
Orally active pivaloyloxymethyl 3-(isoxazolidin-5-yl)cephalosporins.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cephalosporins; Intestinal Absorption; Isoxazoles; Magnetic Resonance Spectroscopy; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests | 1992 |
Studies on condensed-heterocyclic azolium cephalosporins. III. Synthesis and antibacterial activity of 7 beta-[2-(2-amino-5-substituted-thiazol-4-yl)-2 (Z)-alkoxyiminoacetamido]-3-(condensed-heterocyclic azolium)methyl-3-cephem-4- carboxylates.
Topics: Anti-Bacterial Agents; Cefmenoxime; Cefpirome; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests | 1992 |
In-vitro and in-vivo antibacterial activities of E1040, a new cephalosporin with potent antipseudomonal activity.
Topics: Animals; Bacteria; Cefmenoxime; Cefoperazone; Ceftazidime; Ceftizoxime; Cephalosporins; Male; Mice; Mice, Inbred Strains; Microbial Sensitivity Tests; Microscopy, Electron; Pseudomonas aeruginosa; Streptococcal Infections | 1990 |
Application of mathematical model to experimental chemotherapy of fatal murine pneumonia.
Topics: Animals; Cefazolin; Cefmenoxime; Cephalosporins; Klebsiella Infections; Klebsiella pneumoniae; Male; Mice; Mice, Inbred Strains; Models, Biological; Pneumonia | 1990 |
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1990 |
New orally active cephalosporin esters.
Topics: Absorption; Administration, Oral; Animals; Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Esters; Mice; Rats | 1990 |
Comparison of the in vitro and in vivo antibacterial activities of cefepime (BMY-28142) with ceftazidime, cefuzonam, cefotaxime and cefmenoxime.
Topics: Animals; Bacteria; Bacterial Infections; beta-Lactamases; Cefepime; Cefmenoxime; Cefotaxime; Ceftazidime; Ceftizoxime; Cephalosporins; Immunosuppression Therapy; Mice; Microbial Sensitivity Tests | 1989 |
In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Chlamydia trachomatis; Clarithromycin; Erythromycin; Leucomycins; Microbial Sensitivity Tests; Neisseria gonorrhoeae | 1987 |
In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.
Topics: Cefmenoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Erythromycin; Fleroxacin; Haemophilus ducreyi; Humans; Neisseria gonorrhoeae; Penicillins; Spectinomycin; Tetracycline | 1987 |
[Epidemiological and therapeutic studies on gonorrheal infections--clinical efficacy of T-2588. (Sapporo Clinical Research Group for STD)].
Topics: Adolescent; Adult; Age Factors; Cefmenoxime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Male; Middle Aged; Neisseria gonorrhoeae; Sex Factors | 1986 |
In vitro activity of RO 15-8074 and RO 19-5247.
Topics: Amoxicillin; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Enterobacteriaceae; Erythromycin; Haemophilus influenzae; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Staphylococcus; Streptococcus | 1987 |
The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.
Topics: Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Fleroxacin; Neisseria gonorrhoeae; Penicillin Resistance | 1987 |
In vitro activity of Ro 19-5247 (T-2525) and interpretive criteria for disk diffusion susceptibility testing.
Topics: Acinetobacter; Amoxicillin; Bacteria; Cefaclor; Cefmenoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Enterobacteriaceae; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus; Streptococcus | 1987 |
In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.
Topics: Amikacin; Anti-Bacterial Agents; Cefmenoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Drug Combinations; Fleroxacin; Mycobacterium; Nontuberculous Mycobacteria; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1987 |
In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity.
Topics: Bacteria; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefazolin; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Ceftazidime; Cephalosporins; Escherichia coli Proteins; Hexosyltransferases; Humans; Methicillin; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases; Protein Binding; Pseudomonas aeruginosa | 1988 |
Determination of cefotaxime, desacetylcefotaxime, cefmenoxime and ceftizoxime in biological samples by fluorescence detection after separation by thin-layer chromatography.
Topics: Cefmenoxime; Cefotaxime; Ceftizoxime; Cephalosporins; Chromatography, Thin Layer; Humans; Spectrometry, Fluorescence | 1988 |
Therapeutic efficacy of chloramphenicol, co-trimoxazole (trimethoprim/sulphamethoxazole), cefmenoxime and ceftriaxone in experimental bacteraemia and meningitis caused by ampicillin-resistant Haemophilus influenzae type b.
Topics: Ampicillin Resistance; Anti-Infective Agents; Cefmenoxime; Ceftriaxone; Cephalosporins; Chloramphenicol; Colony Count, Microbial; Drug Combinations; Humans; Infant; Male; Meningitis, Haemophilus; Sepsis; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Comparative in vitro activity of the two new oral cephalosporin metabolites RO 19-5247 and RO 15-8074.
Topics: Cefmenoxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests; Staphylococcus; Streptococcus | 1987 |
Quantitation of ceftetrame in human plasma and urine by high-performance liquid chromatography.
Topics: Adult; Cefmenoxime; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Humans; Male; Reference Standards; Spectrophotometry, Ultraviolet | 1987 |
Antimicrobial activity and beta-lactamase stability of SK&F 88070 compared with other agents.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefmenoxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Hydrogen-Ion Concentration; Microbial Sensitivity Tests | 1986 |
In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Ceftizoxime; Cephalosporins; Enzyme Stability; Microbial Sensitivity Tests | 1986 |
[Ototoxicity tests for T-2588 in rats].
Topics: Administration, Oral; Animals; Audiometry; Auditory Fatigue; Auditory Threshold; Cefmenoxime; Cephalosporins; Ear, Inner; Female; Rats; Rats, Inbred Strains; Spiral Lamina; Vestibule, Labyrinth | 1986 |
In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefmenoxime; Cephalexin; Cephalosporins; Chemical Phenomena; Chemistry; Hexosyltransferases; Male; Mice; Mice, Inbred ICR; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Protein Binding | 1987 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
Comparative in vitro antibacterial activities of two new oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074).
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Microbial Sensitivity Tests | 1987 |
[Clinical phase I study of T-2588].
Topics: Administration, Oral; Adult; Cefmenoxime; Cephalosporins; Drug Evaluation; Humans; Kinetics; Male | 1987 |
Preliminary antimicrobial susceptibility interpretive criteria for cefetamet (Ro 15-8074) and cefteram (Ro 19-5247) disk tests.
Topics: Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Computers; Microbial Sensitivity Tests; Predictive Value of Tests; Regression Analysis | 1987 |
In vitro activity of the two new oral cephalosporins RO 15-8074 and RO 19-5247.
Topics: Aztreonam; Cefmenoxime; Ceftizoxime; Cephalexin; Cephalosporins; Cephradine; Enterobacteriaceae; Pseudomonas | 1987 |
In vitro activity of Ro 15-8074 and Ro 19-5247, two orally administered cephalosporin metabolites.
Topics: Bacteria; Blood Proteins; Cefmenoxime; Ceftizoxime; Cephalosporins; Culture Media; Microbial Sensitivity Tests; Protein Binding | 1986 |
[Studies on beta-lactam antibiotics for medicinal purposes. XXI. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (1)].
Topics: Animals; Cefmenoxime; Cephalosporins; Dogs; Kinetics; Male; Mice; Mice, Inbred ICR; Rabbits; Rats; Rats, Inbred Strains; Tissue Distribution | 1986 |
[Studies on beta-lactam antibiotics for medicinal purposes. XXII. Studies on the metabolism of pivaloyloxymethyl (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-3-cephem-4-carboxylate (T-2588) (2)].
Topics: Animals; Cefmenoxime; Cephalosporins; Kinetics; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains | 1986 |
[General pharmacology of T-2588, a new oral cephem antibiotic].
Topics: Animals; Autonomic Nervous System; Blood; Cardiovascular System; Cats; Cefmenoxime; Central Nervous System; Cephalosporins; Dogs; Female; Guinea Pigs; In Vitro Techniques; Kidney; Male; Mice; Mice, Inbred ICR; Muscle, Smooth; Pregnancy; Rabbits; Rats; Rats, Inbred Strains; Respiratory System; Species Specificity | 1986 |
[Studies on absorption, distribution and excretion of 14C labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-oxo-5-thia- 1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate (14C-T
Topics: Administration, Oral; Animals; Blood Proteins; Cefmenoxime; Cephalosporins; Female; Fetus; Intestinal Absorption; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1986 |
[The autoradiographic studies on the distribution of 14C-labeled pivaloyloxymethyl (+)-(6R,7R)- 7-[(Z)-2-(2-amino-4-thiazolyl)-2-methoxyiminoacetamido]- 3-[(5-methyl-2H-tetrazol-2-yl)methyl]-8-o xo-5-thia- 1-azabicyclo [4.2.0]oct-2-ene-2-carboxylate (14C-
Topics: Administration, Oral; Animals; Autoradiography; Blood-Brain Barrier; Cefmenoxime; Cephalosporins; Chemical Phenomena; Chemistry; Female; Fetus; Male; Maternal-Fetal Exchange; Mice; Pregnancy; Tissue Distribution | 1986 |
[Clinical experience with T-2588 in complicated urinary tract infections].
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Bacteria; Cefmenoxime; Cephalosporins; Drug Evaluation; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Urinary Tract Infections | 1986 |
In vitro activities of Ro 19-5247 and Ro 15-8074, new oral cephalosporins.
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Ceftizoxime; Cephalosporins; Microbial Sensitivity Tests | 1986 |
[A subacute oral toxicity study of T-2588 in juvenile rats].
Topics: Administration, Oral; Animals; Body Weight; Cefmenoxime; Cephalosporins; Female; Kidney; Liver; Lung; Male; Organ Size; Rats; Rats, Inbred Strains; Testis | 1986 |
[A study on the disulfiram-like reaction of T-2588. Influence of the consecutive administration of T-2588 on hepatic alcohol dehydrogenase and aldehyde dehydrogenase activities and blood levels of ethanol and acetaldehyde].
Topics: Acetaldehyde; Alcohol Dehydrogenase; Aldehyde Dehydrogenase; Animals; Cefmenoxime; Cephalosporins; Disulfiram; Ethanol; Liver; Male; Rats; Rats, Inbred Strains | 1986 |
[Effect of single or consecutive administration of T-2588 on hepatic-injured male rats].
Topics: Administration, Oral; Aldehyde Dehydrogenase; Animals; Cefmenoxime; Cephalosporins; Chemical and Drug Induced Liver Injury; Liver; Male; Organ Size; Rats; Rats, Inbred Strains | 1986 |
[Pharmacokinetic studies of a new oral cephem T-2588. Pharmacokinetics in gastrectomized volunteers and the renal excretory system in healthy volunteers].
Topics: Adult; Cefmenoxime; Cephalosporins; Gastrectomy; Glomerular Filtration Rate; Humans; Kidney; Kinetics; Male; Tissue Distribution | 1986 |
[Clinical studies on T-2588 in the field of otorhinolaryngology].
Topics: Administration, Oral; Adult; Cefmenoxime; Cephalosporins; Female; Humans; Laryngitis; Male; Middle Aged; Pharyngitis; Sinusitis; Tonsillitis | 1986 |
[Evaluation of T-2588 in the treatment of respiratory tract infection].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Bronchitis; Cefmenoxime; Cephalosporins; Female; Humans; Male; Middle Aged; Pneumonia; Respiratory Tract Infections | 1986 |
[Immunological studies on the antigenicity of the cephem antibiotic T-2588].
Topics: Animals; Antibody Formation; Antibody Specificity; Cefmenoxime; Cephalosporins; Coombs Test; Cross Reactions; Female; Guinea Pigs; Hemagglutination Tests; Immune Sera; Immunoglobulin E; Male; Mice; Passive Cutaneous Anaphylaxis; Rabbits | 1985 |
In vitro antibacterial activity of SK&F 88070 against aerobic gram-positive and gram-negative cocci and Haemophilus influenzae.
Topics: Ampicillin; Cefmenoxime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Haemophilus influenzae; Methicillin; Microbial Sensitivity Tests; Moxalactam | 1985 |
[Comparison of in vitro antibacterial activities of new cephems against clinical organisms (isolated between June 1983 and January 1984)].
Topics: Bacteria; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotetan; Ceftazidime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1985 |
Comparative activity of seven extended-spectrum cephalosporins against gram-negative bacilli from blood cultures.
Topics: Cefmenoxime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Cross Infection; Enterobacteriaceae; Enterobacteriaceae Infections; Gram-Negative Bacteria; Humans; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis | 1985 |
[Clinical studies on combination therapy of cephem antibiotics in chronic complicated urinary tract polymicrobial infections due to Pseudomonas aeruginosa and other bacteria].
Topics: Aged; Bacterial Infections; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Infusions, Parenteral; Male; Middle Aged; Pseudomonas Infections; Urinary Tract Infections | 1984 |
Affinity of cefmenoxime for beta-lactamases: an analysis.
Topics: Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Hydrolysis; Kinetics; Moxalactam; Penicillinase | 1984 |
Antimicrobial activity of cefmenoxime (SCE-1365).
Topics: Animals; Bacteria; Bacterial Infections; Cefamandole; Cefazolin; Cefmenoxime; Cefotaxime; Cefoxitin; Cephalosporins; Drug Synergism; Female; Mice | 1981 |
Beta-lactamase stability and antibacterial activity of cefmenoxime (SCE-1365), a novel cephalosporin.
Topics: Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefmenoxime; Cefotaxime; Cephalosporinase; Cephalosporins; Drug Stability; Microbial Sensitivity Tests; Proteus vulgaris | 1981 |
Synthesis and structure-activity relationships of 7 beta-[2-(2-aminothiazol-4-yl)acetamido]cephalosporin derivatives. VI. Alternative syntheses of 7 beta-[2-(2-aminothiazol-4-yl)-(Z)-2-methoxyiminoacetamido]cephalosporin derivatives.
Topics: Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry | 1981 |
Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: effect of para-aminohippurate on renal clearance and intrarenal distribution of cephalosporins in rabbits.
Topics: Aminohippuric Acids; Animals; Binding, Competitive; Blood Proteins; Cefazolin; Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephaloridine; Cephalosporins; Inulin; Kidney; Male; p-Aminohippuric Acid; Protein Binding; Rabbits | 1981 |
Comparison of the renal excretory mechanisms of cefmenoxime and other cephalosporins: renal clearance in rats and rabbits.
Topics: Animals; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cephalosporins; Half-Life; Kidney; Kidney Tubules; Male; Metabolic Clearance Rate; Protein Binding; Rabbits; Rats; Rats, Inbred Strains | 1981 |
Comparative in vitro activity of cefmenoxime, cefotaxime, cefuroxime, cefoxitin, and penicillin against Neisseria gonorrhoeae.
Topics: beta-Lactamases; Cefmenoxime; Cefotaxime; Cefoxitin; Cefuroxime; Cephalosporins; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin Resistance; Penicillins | 1981 |
[Comparison of antibacterial activity of cefmenoxime with other cephalosporins against clinically isolated bacteria (author's transl)].
Topics: Bacteria; Bacteroides; Cefmenoxime; Cefotaxime; Cephalosporins; Clostridium; Drug Resistance, Microbial; Escherichia coli; Haemophilus influenzae; Klebsiella; Proteus; Streptococcus | 1981 |
A very precise high-performance liquid chromatographic procedure for the determination of cefmenoxime, a new cephalosporin antibiotic, in plasma.
Topics: Cefmenoxime; Cefotaxime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Reference Values; Time Factors | 1982 |
High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine.
Topics: Cefmenoxime; Cefotaxime; Cefotiam; Cefsulodin; Cephalosporins; Chromatography, High Pressure Liquid; Humans | 1982 |
[Antibacterial activities of new cephems against clinically isolated organisms (author's transl)].
Topics: Bacteria; Cefazolin; Cefmenoxime; Cefoperazone; Cefotaxime; Cefotiam; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Gentamicins; Moxalactam; Structure-Activity Relationship | 1982 |
Comparative in vitro activities of cefmenoxime (SCE-1365) and newer cephalosporin derivatives of clinical utility.
Topics: Bacteria; Cefmenoxime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests | 1982 |
[Susceptibility of recent clinical isolates of Pseudomonas aeruginosa and Serratia marcescens to cefotaxime, ceftizoxime, cefmenoxime, latamoxef and cefsulodin in comparison with other beta-lactam antibiotics and aminoglycosides].
Topics: Aminoglycosides; Anti-Bacterial Agents; Cefmenoxime; Cefotaxime; Cefsulodin; Ceftizoxime; Cephalosporins; Cephamycins; Drug Resistance, Microbial; Moxalactam; Pseudomonas aeruginosa; Serratia marcescens | 1982 |
Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.
Topics: Anaerobiosis; Anti-Bacterial Agents; Bacteria; Bacteroides fragilis; Cefmenoxime; Cefotaxime; Cefotetan; Cephalosporins; Cephamycins; Imipenem; Microbial Sensitivity Tests; Thienamycins | 1983 |
Effect of storage temperature and time on stability of cefmenoxime, ceftriaxone, and cefotetan in 5% dextrose injection.
Topics: Cefmenoxime; Cefotaxime; Cefotetan; Ceftriaxone; Cephalosporins; Cephamycins; Drug Stability; Drug Storage; Freezing; Glucose; Temperature; Time Factors | 1983 |
Antimicrobial activity of cefmenoxime compared with those of other cephalosporins.
Topics: Bacteria; Cefmenoxime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests | 1983 |
[In vitro activity of cefmenoxime (SCE 1365) against 616 hospital strains of gram-negative bacilli chosen for beta-lactam resistance. Comparison with cefotaxime, lamoxactam and ceftazidime].
Topics: Anti-Bacterial Agents; Bacteria; Cefmenoxime; Cefotaxime; Ceftazidime; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Enterobacteriaceae; Humans; Moxalactam | 1983 |
Antimicrobial activity of SK&F 88070, an expanded-spectrum cephalosporin with high and prolonged levels in blood.
Topics: Animals; Bacteria; Bacterial Infections; Blood Proteins; Cefmenoxime; Cephalosporins; Kinetics; Male; Mice; Protein Binding; Rats; Rats, Inbred Strains; Saimiri | 1984 |
Metabolic fate of SCE-1365, a new broad-spectrum cephalosporin, after parenteral administration to rats and dogs.
Topics: Absorption; Animals; Bile; Cefmenoxime; Cephalosporins; Dogs; Female; Half-Life; Injections, Intramuscular; Injections, Intravenous; Kidney Tubules; Male; Placenta; Pregnancy; Rats; Species Specificity; Tissue Distribution | 1980 |
Cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
Topics: Animals; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Bacterial Proteins; Bacteriolysis; Carrier Proteins; Cefmenoxime; Cephalosporins; Culture Media; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Escherichia coli Proteins; Hexosyltransferases; Male; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidoglycan Glycosyltransferase; Peptidyl Transferases | 1981 |
Absorption, distribution and excretion of cefmenoxime (SCE-1365), a novel broad-spectrum cephalosporin, in mice, rats, rabbits and dogs.
Topics: Absorption; Animals; Anti-Bacterial Agents; Bile; Cefmenoxime; Cephalosporins; Dogs; Female; Male; Mice; Rabbits; Rats; Tissue Distribution | 1980 |
Synthesis and biological properties of a series of optically active 2-oxaisocephems.
Topics: Animals; Anti-Bacterial Agents; Cefmenoxime; Cephalosporins; Enterococcus faecalis; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Staphylococcus aureus | 1995 |
AUIC--a general target for the optimization of dosing regimens of antibiotics?
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cefmenoxime; Cephalosporins; Ciprofloxacin; Drug Administration Schedule; Humans; Microbial Sensitivity Tests; Models, Biological; Tobramycin | 1996 |
An assessment of antigenic potential of beta-lactam antibiotics, low molecular weight drugs, using guinea pig models.
Topics: Anaphylaxis; Animals; Anti-Bacterial Agents; Antigens; Cefmenoxime; Cefmetazole; Ceftazidime; Cefuroxime; Cephalosporins; Cephalothin; Drug Hypersensitivity; Enzyme-Linked Immunosorbent Assay; Female; Guinea Pigs; Hypersensitivity, Delayed; Intradermal Tests; Passive Cutaneous Anaphylaxis; Piperacillin | 1997 |
In vitro and in vivo antibacterial activities of CS-834, a novel oral carbapenem.
Topics: Administration, Oral; Animals; Bacterial Infections; Bacterial Proteins; beta-Lactamases; Carbapenems; Carrier Proteins; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Drug Stability; Hexosyltransferases; Imipenem; Mice; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pneumonia, Staphylococcal; Prodrugs; Thienamycins | 1997 |
Failure of pre-diarrheal antibiotics to prevent hemolytic uremic syndrome in serologically proven Escherichia coli O157:H7 gastrointestinal infection.
Topics: Adult; Cefmenoxime; Cephalosporins; Child; Child, Preschool; Escherichia coli Infections; Escherichia coli O157; Female; Hemolytic-Uremic Syndrome; Humans; Male; Time Factors; Treatment Failure | 1999 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
Evaluation of oral antimicrobial agent levels in tooth extraction sites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alveolar Process; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefmenoxime; Cefuroxime; Cephalosporins; Female; Humans; Male; Middle Aged; Ofloxacin; Penicillins; Prodrugs; Staphylococcal Infections; Streptococcus; Talampicillin; Time Factors; Tooth Diseases; Tooth Extraction; Tooth Socket | 2001 |
[Antimicrobial susceptibility surveillance of Streptococcus pneumoniae and Haemophilus influenzae isolates to cefteram and other antimicrobial drugs during January 2003 to July 2004].
Topics: Amoxicillin; Anti-Bacterial Agents; beta-Lactamases; Cefmenoxime; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Haemophilus influenzae; Humans; Japan; Streptococcus pneumoniae; Time Factors | 2004 |
Characteristics of Pseudomonas corneal infection related to orthokeratology.
Topics: Administration, Topical; Adolescent; Anti-Bacterial Agents; Cefmenoxime; Cefozopran; Cephalosporins; Contact Lenses; Corneal Ulcer; Drug Therapy, Combination; Eye Infections, Bacterial; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Ofloxacin; Pseudomonas aeruginosa; Pseudomonas Infections | 2005 |